Royal Bank of Canada
ALNA

Royal Bank of Canada’s Allena Pharmaceuticals ALNA Stock Holding History

Royal Bank of Canada’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-237
Closed -$3K – 7305
2018
Q3 		$3K Buy
+237
New +$2.6K ﹤0.01% 6460
2018
Q2 		– Sell
-7
Closed – – 6885
2018
Q1 		$0 Buy
+7
New +$58 ﹤0.01% 6971

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Royal Bank of Canada's ALNA Position: Q4 2018 in Review

Royal Bank of Canada sold out of Allena Pharmaceuticals (ALNA) in Q4 2018, closing a stake of 237 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in ALNA in Q1 2018 and held it in 2 quarters. The position peaked at $3K in Q3 2018. 49 funds tracked by Wall St. Rank hold ALNA as of Q4 2018.

  • Royal Bank of Canada reported no remaining Allena Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Royal Bank of Canada sold 237 Allena Pharmaceuticals shares in Q4 2018, an estimated $3K.
  • Royal Bank of Canada first reported a position in Allena Pharmaceuticals in Q1 2018 and held it in 2 quarters.
  • Royal Bank of Canada's Allena Pharmaceuticals position peaked at $3K in Q3 2018.
  • 49 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2018.

Based on Royal Bank of Canada's 13F filing for Q4 2018, filed 14 Feb 2019.